1988
DOI: 10.1007/bf01975059
|View full text |Cite
|
Sign up to set email alerts
|

Absence of antibodies to HTLV-I/II in French patients with hematological malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

1990
1990
1996
1996

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
1
0
0
Order By: Relevance
“…fact, HTLV-I reactivity has not been found in studies of Spanish patients with various he matological malignancies (including mycosis fungoides, T cell leukemias and lymphomas), subacute myelopathies and autoimmune dis orders [1,5], This is in accordance with the findings of other studies in Europe [6][7][8], which have not identified HTLV-1 seroreactivity in native patients with lymphoprolifér ative syndromes or neurological disease. Thus, HTLV-I infection m patients with neu rological or lymphoproliférative diseases in Spam are probably from, or have been to HTLV-I-endemic regions.…”
Section: Patients With Ham/tspsupporting
confidence: 80%
“…fact, HTLV-I reactivity has not been found in studies of Spanish patients with various he matological malignancies (including mycosis fungoides, T cell leukemias and lymphomas), subacute myelopathies and autoimmune dis orders [1,5], This is in accordance with the findings of other studies in Europe [6][7][8], which have not identified HTLV-1 seroreactivity in native patients with lymphoprolifér ative syndromes or neurological disease. Thus, HTLV-I infection m patients with neu rological or lymphoproliférative diseases in Spam are probably from, or have been to HTLV-I-endemic regions.…”
Section: Patients With Ham/tspsupporting
confidence: 80%